Back to search

Treatment of Gaucher disease with an enzyme inhibitor

Data up to Jan 2025

Published1996
Citations120
References20

Total Citations Per Year

Abstract

References (20)

Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase

1987 • 254 citations

N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.

1994 • 175 citations

Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth.

1995 • 148 citations

Increased risk of cancer in patients with gaucher disease

1993 • 124 citations

Inhibition of Sphingolipid Synthesis by Cycloserine In Vitro and In Vivo

1984 • 110 citations

Effects of D‐threo‐PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells

1989 • 99 citations

A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.

1993 • 95 citations

Antitumor activity via inhibition of glycosphingolipid biosynthesis

1987 • 74 citations

Epithelial glucosphingolipid expression as a determinant of bacterial adherence and cytokine production

1994 • 62 citations

A ceramide analogue (PDMP) inhibits glycolipid synthesis in fish embryos

1992 • 45 citations

Stimulation of liver growth and DNA synthesis by glucosylceramide

1988 • 44 citations

Rapid kidney changes resulting from glycosphingolipid depletion by treatment with a glucosyltransferase inhibitor

1991 • 28 citations

Metabolism of D-[3H]threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis, and the synergistic action of an inhibitor of microsomal monooxygenase

1991 • 26 citations

Control of kidney size by sex hormones: possible involvement of glucosylceramide

1992 • 26 citations

Effects of the glucosphingolipid synthesis inhibitor, PDMP, on lysosomes in cultured cells.

1994 • 26 citations

Human glucocerebrosidase catalyses transglucosylation between glucocerebroside and retinol

1994 • 23 citations

Brain Glucocerebrosidase in Gaucher's Disease

1982 • 18 citations

Changes in liver lipids after administration of 2‐decanoylamino‐3‐morpholinopropiophenone and chlorpromazine

1982 • 15 citations

Uptake by neuroblastoma cells of glucosylceramide, glucosylceramide glucosidase, its stimulator protein, and phosphatidylserine

1986 • 15 citations

Normalization of liver glucosylceramide levels in the “Gaucher” mouse by phosphatidylserine injection

1988 • 14 citations

Cited By (0)

Loading...
Treatment of Gaucher disease with an enzyme inhibitor (1996) – Glycoconjugate Journal | Metascience Observatory Explorer